Loading chart…
PRE-MARKET
Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations.
Kopran Limited (KOPRAN) is listed on the NSE in the Healthcare sector, Drug Manufacturers - General industry. The KOPRAN share price is ₹263.20 (-0.79% today), with a market capitalisation of ₹13B and a price-to-earnings (P/E) ratio of 50.9. MarketRipple tracks the KOPRAN investment thesis, the ripple-chain impact of market events on Kopran Limited, and the Healthcare sector outlook.
Open
₹264.00
High
₹269.70
Low
₹262.00
Prev. Close
₹265.30
52W High
₹295.83
52W Low
₹107.00
Day range
₹262.00–₹269.70
52-week range
₹107.00–₹295.83
Volume
61K
P/E
50.9
ROE
4.9%
D/E
0.29
Margin
3.6%
Kopran Limited (NSE: KOPRAN) is currently trading at ₹263.20 (-0.79%).
Kopran Limited's market capitalization is ₹13B.
Kopran Limited's price-to-earnings (P/E) ratio is 50.9.
Kopran Limited operates in the Healthcare sector (Drug Manufacturers - General).